Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
A Randomized Trial of Tap Water Treatment in the Elderly Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about A Randomized Trial of Tap Water Treatment in the Elderly conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. A Randomized Trial of Tap Water Treatment in the Elderly Clinical research trials and A Randomized Trial of Tap Water Treatment in the Elderly health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including A Randomized Trial of Tap Water Treatment in the Elderly. A Randomized Trial of Tap Water Treatment in the Elderly Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a A Randomized Trial of Tap Water Treatment in the Elderly clinical trial. Human subjects often get the best healthcare possible for their A Randomized Trial of Tap Water Treatment in the Elderly condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.

Home > "A" Clinical Trials Conditions > A Randomized Trial of Tap Water Treatment in the Elderly

A Randomized Trial of Tap Water Treatment in the Elderly



A Randomized Trial of Tap Water Treatment in the Elderly

For Condition: Gastrointestinal Diseases,Diarrhea
Status: Recruiting
Sponsor(s): National Institute on Aging (NIA) ,
Synopsis: This study is being conducted in Sonoma County, California. Gastrointestinal illness and diarrhea are recognized as a significant cause of morbidity and mortality in the elderly. One study showed that 51% of deaths caused by diarrhea over a 9-year period occurred in individuals over the age of 74 years. Although many infectious diseases are more problematic in the elderly because of a decline in immune function and a higher incidence of pre-existing malnutrition and dehydration, it is still not known what the principal modes of transmission are and which infectious agents are responsible. The principal objective of this study is to evaluate the ability of in-home treatment of tapwater to reduce gastrointestinal illness in non-institutionalized elderly individuals. The trial will test household-level treatment of drinking water by joint use of ultraviolet light and filtration devices. A secondary objective is an estimate of the incidence of specific bacterial, viral, and protozoan agents in stool specimens collected from elderly individuals with gastrointestinal symptoms that might be related to water consumption.
Details: There is heated debate in the United States about the extent to which waterborne infectious diseases may be transmitted to human beings through drinking water that meets federal standards for pathogen removal. This debate is even more pronounced among elderly immunocompromised persons and their health care providers because of the prolonged illness syndromes (generally gastrointestinal) and even death that may occur in these persons after the ingestion of infectious agents. Concerns about drinking water have been heightened by the findings of Payment et. al. in Canada which suggested that approximately 25% of "highly credible" gastrointestinal illness in a community might be due to drinking water. Gastrointestinal illness and diarrhea are recognized as a significant cause of morbidity and mortality in the elderly. One study showed that 51% of deaths caused by diarrhea over a 9-year period occurred in individuals over the age of 74 years (Lew et al. 1991). In a review of sensitive populations, Gerba et al. (1996) reported case fatality rates for specific enteric pathogens 10 to 100 times higher in this group compared to the general population. Although many infectious diseases are more problematic in the elderly because of a decline in immune function and a higher incidence of pre-existing malnutrition and dehydration, it is still not known what the principal modes of transmission are and which infectious agents are responsible. Furthermore, studies on gastrointestinal illness in the elderly are important now because of an expanding elderly population and the heightened interest in the development of vaccine strategies. These developments necessitate a clearer understanding of the relative contribution of various pathogens to gastrointestinal illness in this population. Although many agents responsible for gastrointestinal illness have previously been difficult to identify reliably, state-of-the-art laboratory technology, including molecular methods, now make such study more feasible. We will use laboratory techniques to identify the specific causal agents of gastrointestinal illness in the intervention and placebo groups and to estimate the relative prevalence of these pathogens as a cause of gastrointestinal illness. This study is a randomized, triple-blinded, placebo-controlled, intervention trial in an elderly population (i.e. over 55 years of age). The intervention to be tested is household-level treatment of drinking water by joint use of ultraviolet light and filtration devices in the form of a point-of-use, countertop unit. The project site is the city of Sonoma, California, and adjacent regions of southern Sonoma County also served by the Sonoma County Water Agency, that receive their drinking water from ground water aquifers under the Russian River. The unit of randomization and intervention will be individual households. The unit of analysis will be the individual participants within households, adjusted for intra-household clustering (i.e. the within-household correlation). The participants, the study investigators and the data analysts will be blinded to the assignment of individual households to active or placebo device except for one study staff member who will keep the randomization codes. This un-blinded staff member will not have contact with any of the study participants, nor will he/she have access to any data on the study participants during the course of the study. The primary objective is to determine the incidence of gastrointestinal disease in a group of households using a home drinking water device (combined filtration/UV light) and in a group of households receiving a placebo device that is inactive but identical in appearance. This information will be used to estimate the burden of gastrointestinal illness in an elderly population due to the consumption, at home, of drinking water that meets regulatory standards but receives no additional treatment. A secondary objective is an estimate of the incidence of specific bacterial, viral, and protozoan agents in stool specimens collected from elderly individuals with gastrointestinal symptoms, and that might be related to water consumption. To determine the rates of asymptomatic infections, we will also test stool specimens from individuals who are not sick. Further questions about seroprevalence of these waterborne pathogens and the immune response they elicit will be answered by testing serum samples taken from all participants at critical junctures during the study.
Eligibility:
Study Type:
  Interventional, Prevention, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Efficacy Study
Minimum Age/Maximum Age: 55 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria - 55 years or older - primary source of drinking water used at home is supplied by Sonoma County Water Agency without use of home filtration device or bottled water - all individuals living in the home must sign informed consent and agree to have the water treatment device installed - no known immunocompromising conditions (including HIV/AIDS, active cancer, or transplant recipients). Exclusion criteria: - persons with immunocompromising condition (including HIV/AIDS, active cancer, or transplant recipients) - employees and family members of the Sonoma County Water Agency or a Sonoma County Water District
Total Enrollment: 810

Location and Contact Information:

Overall Study Official:
JohnColford,  Principal Investigator,  School of Public Health, University of California at Berkeley

University of California Berkeley *Recruiting*
Berkeley,  California,  94720
United States
Recruiting Catherine  Wright 510-643-5378


Additional Information:
Study ID Numbers:
  AG0002;  5R01AG016634-03
Study Start Date: January 2000
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00058942

Other Gastrointestinal Diseases Studies:
1. STOP Trial - Sandostatin LAR Depot Trial for the Optimum Prevention of Chemotherapy Induced Diarrhea

2. A phase II, randomized, open-label, controlled, dose-elevation, multicenter trial of an investigational drug for the prevention of diarrhea associated with Irinotecan/5FU/Leucovorin chemotherapy in patients with previously untreated metastatic colorectal cancer

3. Safety Study of the Chemotherapy Modulator PHY906 in Patients With Advanced Colorectal Cancer

4. Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis

5. A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients

Related Studies:

Other Gastrointestinal Diseases Clinical Trials
Other California Clinical Trials
Other Berkeley Clinical Trials

A Randomized Trial of Tap Water Treatment in the Elderly

Modify your Search

  Other Gastrointestinal Diseases Clinical Trials
  Other California Clinical Trials
  Other Berkeley Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103